Inhibition of smooth muscle force generation by focal adhesion kinase (FAK) inhibitors in the hyperplastic human prostate.
In conclusion, α1-adrenergic smooth muscle contraction or its regulation involves FAK in the human prostate. Consequently, FAK may be involved in pathophysiology of LUTS, and in current or future LUTS therapies.
PMID: 25056351 [PubMed - as supplied by publisher]
Source: Am J Physiol Renal P... - Category: Urology & Nephrology Authors: Kunit T, Gratzke C, Schreiber A, Strittmatter F, Waidelich R, Rutz B, Loidl W, Andersson KE, Stief CG, Hennenberg M Tags: Am J Physiol Renal Physiol Source Type: research
More News: Benign Prostatic Hyperplasia | Urology & Nephrology